Inflachromene ameliorates Parkinson's disease by targeting Nrf2-binding Keap1
Journal article published in 2024 by
Junhyeong Yim 
,
Yoon Soo Hwang ,
Jae-Jin Lee,
Ju Hee Kim,
Jeong Yeob Baek ,
Jaeyeong Jeong,
Young Il Choi ,
Byung Kwan Jin,
Seung Bum Park
,
Yoon Soo Hwang ,
Jae-Jin Lee,
Ju Hee Kim,
Jeong Yeob Baek ,
Jaeyeong Jeong,
Young Il Choi ,
Byung Kwan Jin,
Seung Bum Park
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 
Abstract
Target identification using fluorescence difference in two-dimensional gel electrophoresis (FITGE) revealed the molecular mechanism of ICM that ameliorates PD by targeting a specific form of Keap1.